George Morrow's Trading History
| ALGNAlign Tech | May 22, 2026 | Director | Uninformative Buy | 285.10K | $1.25M | |
| NBIXNeurocrine | May 21, 2026 | Director | Uninformative Buy | 513.20K | $1.52M | |
| FRTXFresh Tracks Therapeutics | May 26, 2015 | ― | Uninformative Buy | 75.00 | $25.57K | |
| AMGNAmgen | Apr 30, 2010 | Exe VP, Global Commercial Ops | Uninformative Sell | 81.51K | $62.07M | |
| OTICOtonomy | ― | ― | ― | $0.00 | ||
| SWYSafeway Inc | ― | ― | ― | ― |
You May Also Like
George Morrow insider profile FAQ
What is the percentage of profitable transactions made by George Morrow?
The percentage of profitable transactions made by George Morrow is 25%.
What is the average return per transaction made by George Morrow?
The average return per transaction made by George Morrow is -25.20%.
What stocks does George Morrow hold?
George Morrow holds: NBIX, ALGN, FRTX, SWY, OTIC, AMGN stocks.
What was George Morrow’s latest transaction?
George Morrow’s latest transaction was an Uninformative Buy of $285.10K.
What was George Morrow's most profitable transaction?
George Morrow’s most profitable transaction was an Informative Sell of ALGN stock on August 3, 2021. The return on the trade was 59.10%.
What is George Morrow's role in Neurocrine?
George Morrow's role in Neurocrine is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.